-
1 Comment
Nexus AG is currently in a long term uptrend where the price is trading 19.1% above its 200 day moving average.
From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.2.
Nexus AG's total revenue rose by 14.5% to $47M since the same quarter in the previous year.
Its net income has increased by 45.3% to $6M since the same quarter in the previous year.
Finally, its free cash flow grew by 178.6% to $3M since the same quarter in the previous year.
Based on the above factors, Nexus AG gets an overall score of 5/5.
Industry | Health Information Services |
---|---|
Sector | Healthcare |
ISIN | DE0005220909 |
CurrencyCode | EUR |
Exchange | F |
PE Ratio | 45.73 |
---|---|
Market Cap | 979M |
Beta | 0.82 |
Dividend Yield | 0.4% |
Target Price | 65.3 |
Nexus AG develops and sells software and hardware solutions, and provides information technology (IT) services, primarily for customers in the health care system worldwide. It operates through two segments, Healthcare Software and Healthcare Services. The company offers information systems, such as NEXUS/HIS and KIS for somatic hospitals; NEXUS/PSYCHIATRY for psychiatric institutions; NEXUS/REHAB for rehabilitation facilities; ITR, a software for rehabilitation, clinics, and hotels with medical care; NEXUS/ARCHIVE and PEGASOS, an archiving and process management system; NEXUS/QM for quality management; NEXUS/INTEGRATION SERVER, an interface management; NEXUS/CLOUD IT, outsourcing solution; NEXUS/EPS, a software solution to supplement SAP personnel management, as well as process and HR consulting in the SAP environment; ifa systems, an ophthalmology software solution; Sophrona solutions, ophthalmology patients and referral program; and NEXUS/DIS, interdisciplinary diagnostic information system. Its information systems also comprise NEXUS/SWISSLAB, a laboratory information system; NEXUS/LAURIS for order communication in diagnostics; NEXUS/PATHOLOGY and NEXUS/CYTOLOGY, dc-Pathos and dc-LabMan for pathological and cytological devices, print management for cassette, and slide printers; NEXUs/CHILI, for PACS and teleradiology solutions; NEXUS/ASTRAIA for obstetrics and gynecology; NEXUS/SPECIAL DIAGNOSTICS and Clinic WinData for medical specialist diagnostics and device integration; NEXUS/HIS, for somatic hospitals in Switzerland; NEXUS/HOME for senior citizen and nursing homes; NEXUS/OUTPATIENT CARE and Asebis, a homecare solution; and NEXUS/PAT, an administration system for hospitals. In addition, the company offers SINAPSI, osoTEC, highsystemNET, CREATIV OM, SEXTANT, Emed, NEXUS/EPD, NEXUS/AEMP, NEXUS/SPM, EuroSDS, RVS Software, NEXUS/VITA and TESIS VITA, NEXUS/ESKULAP, One ICT, PathoPro, IBS, Heimsoft, Wintime 2000, and GEPADO Xpro. NEXUS AG is headquartered in Donaueschingen, Germany.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for NXU.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024